These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.
    Author: Berenguer J, González J, Pulido F, Padilla B, Casado JL, Rubio R, Arribas JR, Madrid Group for the Study of Discontinuation of Secondary Prophylaxis in Patients with CMV Retinitis.
    Journal: Clin Infect Dis; 2002 Feb 01; 34(3):394-7. PubMed ID: 11753827.
    Abstract:
    We performed a prospective study of discontinuation of secondary prophylaxis against cytomegalovirus (CMV) in 36 patients with acquired immunodeficiency syndrome and quiescent CMV retinitis after successful treatment with highly active antiretroviral therapy (HAART). No reactivation or progression of retinitis was observed in 35 patients with persistent response to HAART, findings that support the discontinuation of secondary prophylaxis against CMV retinitis in such patients.
    [Abstract] [Full Text] [Related] [New Search]